Herbalife COO amends filing on 33,301 SAR grant

Rhea-AI Filing Summary

HERBALIFE LTD. Chief Operating Officer Troy Hicks filed an amended insider report reflecting a prior grant of 33,301 stock appreciation rights (SARs). The amendment is solely to correct the exercise price previously reported as $10.51; all other details remain unchanged. The SARs were granted under the Amended and Restated 2023 Stock Incentive Plan and will vest in three equal installments on February 25, 2027, 2028, and 2029, subject to his continued service.

Insider Trade Summary

Grant/Award: 33,301 shares

Grant/Award 1 txn

Insider Hicks Troy

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Rights	33,301	$0.00	$0.00

Holdings After Transaction: Stock Appreciation Rights — 33,301 contracts (Direct)

Footnotes (2)

1. F1. This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed.
2. F2. Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Herbalife (HLF) report for Troy Hicks?

Herbalife reported an amended insider filing for Chief Operating Officer Troy Hicks covering 33,301 stock appreciation rights (SARs). The filing updates the exercise price disclosure for this previously reported equity award while leaving all other terms of the grant unchanged.

Why was the Herbalife (HLF) Form 4/A for Troy Hicks filed?

The Form 4/A was filed solely to correct the exercise price of previously reported stock appreciation rights, which had been disclosed as $10.51. According to the filing, no other information from the original Form 4 was modified or updated.

How many stock appreciation rights were granted to Herbalife (HLF) COO Troy Hicks?

Chief Operating Officer Troy Hicks was granted 33,301 stock appreciation rights (SARs) under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. This derivative award is reflected in the amended insider filing as an acquisition of derivative securities at no reported cost per right.

What are the vesting terms of Troy Hicks’ Herbalife (HLF) stock appreciation rights?

The 33,301 SARs granted to Troy Hicks vest in three equal one-third installments. Vesting dates are February 25, 2027, February 25, 2028, and February 25, 2029, and each tranche requires his continued service with Herbalife through the applicable vesting date.

Does the Herbalife (HLF) Form 4/A change Troy Hicks’ overall equity award amount?

No, the Form 4/A states it is filed solely to correct the exercise price that was previously reported. The number of stock appreciation rights granted and all other aspects of the original equity award remain the same as initially disclosed.

Is the Troy Hicks Herbalife (HLF) Form 4/A a new transaction or a correction?

The Form 4/A represents a correction, not a new equity grant. It amends the earlier filing only to update the exercise price information for the already reported 33,301 stock appreciation rights, with no other terms or figures altered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 09:25 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hicks Troy

(Last) (First) (Middle)

800 WEST OLYMPIC BLVD.

SUITE 406

(Street)

LOS ANGELES CA 90015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HERBALIFE LTD. [ HLF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$19.26(1)	02/25/2026		A		33,301		(2)	02/25/2036	Common Stock	33,301	$0	33,301	D

Explanation of Responses:

1. This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed.

2. Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date.

	/s/ Alaaeddine Sahibi, as Attorney-In-Fact for Troy Hicks	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.